Skip to main content

4 Result(s)

within Article Remove this filter D Porter Remove this filter Hematology Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

    The original article contains several small errors. The errors & concurrent corrections are listed below [1]:

    D. Porter, N. Frey, P. A. Wood, Y. Weng, S. A. Grupp in Journal of Hematology & Oncology (2018)

    Download PDF (245 KB) View Article

  2. Article

    Erratum: Smac mimetics: implications for enhancement of targeted therapies in leukemia

    Correction to: Leukemia (2010) 25, 2100–2109; doi:10.1038/leu.2010.212 Owing to a typesetting error, the following sentence was incorrectly printed in the abstract section of the article: ‘The novel inhibitor ...

    E Weisberg, A Ray, R Barrett, E Nelson, A L Christie, D Porter, C Straub… in Leukemia (2011)

    Download PDF (90 KB) View Article

  3. No Access

    Article

    Smac mimetics: implications for enhancement of targeted therapies in leukemia

    Drug resistance is a growing concern with clinical use of tyrosine kinase inhibitors. Utilizing in vitro models of intrinsic drug resistance and stromal-mediated chemoresistance, as well as functional mouse model...

    E Weisberg, A Ray, R Barrett, E Nelson, A L Christie, D Porter, C Straub… in Leukemia (2010)

  4. No Access

    Article

    Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy

    Nonmyeloablative allogeneic stem cell transplantation (NMASCT) can be used to exploit the graft-versus-tumor (GVT) potential of allogeneic donor cells in the setting of reduced conditioning regimen toxicity. ...

    R. Buckanovich, G. Liu, C. Stricker, S. Luger, E. Stadtmauer… in Annals of Hematology (2002)